Jeremiah A Alt1, Timothy L Smith, Jess C Mace, Zachary M Soler. 1. Department of Otolaryngology-Head and Neck Surgery, Division of Rhinology and Sinus Surgery, Oregon Sinus Center, Oregon Health and Science University, Portland, Oregon.
Abstract
OBJECTIVES/HYPOTHESIS: To evaluate sleep quality in patients with chronic rhinosinusitis (CRS) using a validated outcome measure and to compare measures of CRS disease severity with sleep dysfunction. STUDY DESIGN: Cross-sectional evaluation of a multi-center cohort. METHODS: According to the 2007 Adult Sinusitis Guidelines, patients with CRS were prospectively enrolled from four academic, tertiary care centers across North America. Each subject completed the Pittsburgh Sleep Quality Index (PSQI) instrument, in addition to CRS-specific measures of quality-of-life (QOL), endoscopy, computed tomography (CT), and olfaction. Patient demographics, comorbid conditions, and clinical measures of disease severity were compared between patients with "good" (PSQI; ≤5) and "poor" (PSQI; > 5) sleep quality. RESULTS: Patients (n = 268) reported a mean PSQI score of 9.4 (range: 0-21). Seventy-five percent of patients reported PSQI scores above the traditional cutoff, indicating poor sleep quality. Patients with poor sleep quality were found to have significantly worse QOL scores on both the Rhinosinusitis Disability Index (P < 0.001) and 22-item Sinonasal Outcome Test (P < 0.001). No significant differences in average endoscopy, CT, or olfactory function scores were found between patients with good or poor sleep quality. Tobacco smokers reported worse average PSQI total scores compared to nonsmokers (P = 0.030). Patients reporting poor sleep were more likely to have a history of depression, even after controlling for gender (P = 0.020). CONCLUSION: The majority of patients with CRS have a poor quality of sleep, as measured by the PSQI survey. Poor sleep quality is significantly associated with CRS-specific QOL, gender, comorbid depression, and tobacco use, but not CT score or endoscopy grade. LEVEL OF EVIDENCE: 2b.
OBJECTIVES/HYPOTHESIS: To evaluate sleep quality in patients with chronic rhinosinusitis (CRS) using a validated outcome measure and to compare measures of CRS disease severity with sleep dysfunction. STUDY DESIGN: Cross-sectional evaluation of a multi-center cohort. METHODS: According to the 2007 Adult Sinusitis Guidelines, patients with CRS were prospectively enrolled from four academic, tertiary care centers across North America. Each subject completed the Pittsburgh Sleep Quality Index (PSQI) instrument, in addition to CRS-specific measures of quality-of-life (QOL), endoscopy, computed tomography (CT), and olfaction. Patient demographics, comorbid conditions, and clinical measures of disease severity were compared between patients with "good" (PSQI; ≤5) and "poor" (PSQI; > 5) sleep quality. RESULTS:Patients (n = 268) reported a mean PSQI score of 9.4 (range: 0-21). Seventy-five percent of patients reported PSQI scores above the traditional cutoff, indicating poor sleep quality. Patients with poor sleep quality were found to have significantly worse QOL scores on both the Rhinosinusitis Disability Index (P < 0.001) and 22-item Sinonasal Outcome Test (P < 0.001). No significant differences in average endoscopy, CT, or olfactory function scores were found between patients with good or poor sleep quality. Tobacco smokers reported worse average PSQI total scores compared to nonsmokers (P = 0.030). Patients reporting poor sleep were more likely to have a history of depression, even after controlling for gender (P = 0.020). CONCLUSION: The majority of patients with CRS have a poor quality of sleep, as measured by the PSQI survey. Poor sleep quality is significantly associated with CRS-specific QOL, gender, comorbid depression, and tobacco use, but not CT score or endoscopy grade. LEVEL OF EVIDENCE: 2b.
Authors: Adam P Spira; Sherry A Beaudreau; Katie L Stone; Eric J Kezirian; Li-Yung Lui; Susan Redline; Sonia Ancoli-Israel; Kristine Ensrud; Anita Stewart Journal: J Gerontol A Biol Sci Med Sci Date: 2011-09-20 Impact factor: 6.053
Authors: Elena Hernández Martínez-Lapiscina; Elena Hernández Martínez De Lapiscina; María Elena Erro; María Elena Erro Aguirre; Teresa Ayuso; Teresa Ayuso Blanco; Ivonne Jericó; Ivonne Jericó Pascual Journal: Muscle Nerve Date: 2012-08 Impact factor: 3.217
Authors: Richard M Rosenfeld; David Andes; Neil Bhattacharyya; Dickson Cheung; Steven Eisenberg; Theodore G Ganiats; Andrea Gelzer; Daniel Hamilos; Richard C Haydon; Patricia A Hudgins; Stacie Jones; Helene J Krouse; Lawrence H Lee; Martin C Mahoney; Bradley F Marple; Col John P Mitchell; Robert Nathan; Richard N Shiffman; Timothy L Smith; David L Witsell Journal: Otolaryngol Head Neck Surg Date: 2007-09 Impact factor: 3.497
Authors: G Merlino; L Fratticci; C Lenchig; M Valente; D Cargnelutti; M Picello; A Serafini; P Dolso; G L Gigli Journal: Sleep Med Date: 2008-01-22 Impact factor: 3.492
Authors: Waleed M Abuzeid; Jess C Mace; Milena L Costa; Luke Rudmik; Zachary M Soler; Grace S Kim; Timothy L Smith; Peter H Hwang Journal: Int Forum Allergy Rhinol Date: 2016-02-16 Impact factor: 3.858
Authors: Adam S DeConde; Jeffrey D Suh; Jess C Mace; Jeremiah A Alt; Timothy L Smith Journal: Int Forum Allergy Rhinol Date: 2015-04-23 Impact factor: 3.858
Authors: Jeremiah A Alt; Andrew J Thomas; Karen Curtin; Jathine Wong; Luke Rudmik; Richard R Orlandi Journal: Int Forum Allergy Rhinol Date: 2017-03-08 Impact factor: 3.858
Authors: Luke Rudmik; Timothy L Smith; Rodney J Schlosser; Peter H Hwang; Jess C Mace; Zachary M Soler Journal: Laryngoscope Date: 2014-03-11 Impact factor: 3.325